VRTX498.01+0.26%
VRTX · US
1y range: 423.24 → 499.65 · as of 2026-07-01
Next earnings
2026-07-30
in 27d
Recent material news
- Vertex Says Pediatric CASGEVY Data Show Consistent Benefits In Rare Blood Disorders2026-06-11T12:20
- Vertex Says CASGEVY Pediatric Data Demonstrate Transformative Potential In Children Ages 5–11 With Severe SCD And Transfusion-Dependent Beta Thalassemia2026-06-11T03:00
- Should FDA’s IgA Nephropathy BLA Acceptance for Povetacicept Reshape Vertex Pharmaceuticals’ (VRTX) Investment Narrative?2026-06-02T16:09
- FDA Accepts Vertex's BLA for Povetacicept in IgA Nephropathy2026-06-02T15:09
Want this depth on every stock you watch?
ThickerPeek writes a daily AI digest on 165+ stocks, weekly theses, earnings briefings, and alerts — for €19/mo. Free tier available.
Not investment advice. ThickerPeek is a research tool. AI-written content is informational, not a buy/sell recommendation. Investment decisions are your own responsibility.